Corient Private Wealth’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Buy |
18,536
+6,592
| +55% | +$117K | ﹤0.01% | 2021 |
|
|
2025
Q1 | $213K | Buy |
+11,944
| New | +$213K | ﹤0.01% | 2034 |
|
|
2023
Q2 | – | Sell |
-4,932
| Closed | -$297K | – | 2108 |
|
|
2023
Q1 | $297K | Buy |
4,932
+1,912
| +63% | +$115K | ﹤0.01% | 1602 |
|
|
2022
Q4 | $222K | Buy |
+3,020
| New | +$222K | ﹤0.01% | 1450 |
|